Open Access
Issue
BIO Web Conf.
Volume 237, 2026
2026 8th International Conference on Biotechnology and Biomedicine (ICBB 2026)
Article Number 01020
Number of page(s) 8
Section Molecular and Cellular Pathophysiology
DOI https://doi.org/10.1051/bioconf/202623701020
Published online 10 June 2026
  • H. Sun, P. Saeedi, S. Karuranga, M. Pinkepank, K. Ogurtsova, B.B. Duncan, C. Stein, A. Basit, J.C.N. Chan, J.C. Mbanya, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022). [Google Scholar]
  • R.Z. Alicic, M.T. Rooney, K.R. Tuttle. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin. J. Am. Soc. Nephrol. 12, 2032–2045 (2017). [Google Scholar]
  • L. Zhang, J. Long, W. Jiang, Y. Shi, X. He, Z. Zhou, Y. Li, R.O. Yeung, J. Wang, K. Matsushita, et al. Trends in Chronic Kidney Disease in China. N. Engl. J. Med. 375, 905–906 (2016). [Google Scholar]
  • H. Chang, H. You, Y. Yao, Y. Zheng, J. Mao, Y. Yao, M. Wang, X. Wang, J. Chen. eGFR-ACR Risk Stratification of Rapid Kidney Function Decline Across Aging Phenotypes in Older Chinese Adults. Clin. Interv. Aging 2025, 2105–2118 (2025). [Google Scholar]
  • F. Persson, P. Rossing. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int. Suppl. 8, 2–7 (2018). [Google Scholar]
  • S. Zhou, N. Luo, H. Si, W. Da, Y. Liu, L. Wu, M. Li, B. Shen. Association between dynapenic abdominal obesity and arthritis among the middle-aged and older Chinese: a longitudinal study. Aging Clin. Exp. Res. 36, 198 (2024). [Google Scholar]
  • P. Zhang, D. Mo, C. Dong, W. Zeng, N. Li, J. Wu, G. Wang, H. Dai. The association of non-HDL-C, NHHR, RC, and RCII with coronary artery stenosis severity in patients with acute coronary syndrome combined with cardiometabolic multimorbidity. Front. Endocrinol. 16, 1701364 (2025). [Google Scholar]
  • F. Guerrero-Romero, L.E. Simental-Mendía, M. Gonzalez-Ortiz, E. Martínez-Abundis, M.G. Ramos-Zavala, S.O. Hernandez-Gonzalez, O. Jacques-Camarena, M. Rodríguez-Moran. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J. Clin. Endocrinol. Metab. 95, 3347–3351 (2010). [Google Scholar]
  • N.N. Aslan Çin, H. Yardımcı, N. Koç, S.A. Uçaktürk, M. Akçil Ok. Triglycerides/high-density lipoprotein cholesterol is a predictor similar to the triglyceride-glucose index for the diagnosis of metabolic syndrome using International Diabetes Federation criteria of insulin resistance in obese adolescents: a cross-sectional study. J. Pediatr. Endocrinol. Metab. 33, 777–784 (2020). [Google Scholar]
  • F. Artunc, E. Schleicher, C. Weigert, A. Fritsche, N. Stefan, H.-U. Häring. The impact of insulin resistance on the kidney and vasculature. Nat. Rev. Nephrol. 12, 721–737 (2016). [Google Scholar]
  • D. Huang, Y. He. Association between non-high-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio and macroalbuminuria: evidence from NHANES 1999-2018. Front. Endocrinol. 16, 1503780 (2025). [Google Scholar]
  • F. Zhu, W. Gan, H. Mao, S. Nie, X. Zeng, W. Chen. Association between the triglyceride-glucose index and major adverse cardiovascular events in patients with chronic kidney disease stages 3-4. Sci. Rep. 15, 28538 (2025). [Google Scholar]
  • Y. Zhao, Y. Hu, J.P. Smith, J. Strauss, G. Yang. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int. J. Epidemiol. 43, 61–68 (2014). [Google Scholar]
  • K.M. Andrassy. Comments on ‘kdigo 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’. Kidney Int. 84, 622–623 (2013). [Google Scholar]
  • Am. Diabetes Assoc. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2023. Diabetes Care 46, S191–S202 (2023). [Google Scholar]
  • X. Zhang, B. Wang, J. Yang, J. Wang, Y. Yu, C. Jiang, L. Xie, Y. Song, B. Zhong, Y. Li, et al. Serum Lipids and Risk of Rapid Renal Function Decline in Treated Hypertensive Adults With Normal Renal Function. Am. J. Hypertens. 32, 393–401 (2019). [Google Scholar]
  • Y. Xin, Y. Wang, Y. Shu, H. Liang, Y. Yang. Correlation between conventional and unconventional lipid parameters with the risk of progression of renal function decline: insights from the China Health and Retirement Longitudinal Study 2011-2015. Ren. Fail. 47, 2499229 (2025). [Google Scholar]
  • M. Forbes, M. Mohebbi, R.L. Woods, M. Lotfaliany, C.F. Reynolds III, A. O’Neil, J.J. McNeil, M. Berk. Triglyceride-glucose index and its association with depressive symptoms in older adults: a longitudinal analysis. J. Affect. Disord. 2025 (2025). [Google Scholar]
  • A. Mitrofanova, S. Merscher, A. Fornoni. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat. Rev. Nephrol. 19, 629–645 (2023). [Google Scholar]
  • X.Z. Ruan, Z. Varghese, J.F. Moorhead. An update on the lipid nephrotoxicity hypothesis. Nat. Rev. Nephrol. 5, 713–721 (2009). [Google Scholar]
  • Y. Song, J. Liu, K. Zhao, L. Gao, J. Zhao. Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases. Cell Metab. 33, 1911–1925 (2021). [Google Scholar]
  • J. Rong, Z. Zhang, X. Peng, P. Li, T. Zhao, Y. Zhong. Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome. Int. J. Biol. Sci. 20, 4783 (2024). [Google Scholar]
  • S.Y. Chae, Y. Kim, C.W. Park. Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia. Antioxidants 12, 2083 (2023). [Google Scholar]
  • R.A. DeFronzo, W.B. Reeves, A.S. Awad. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat. Rev. Nephrol. 17, 319–334 (2021). [Google Scholar]
  • Y. Lytvyn, P. Bjornstad, D.H. van Raalte, H.L. Heerspink, D.Z.I. Cherney. The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications. Endocr. Rev. 41, 202–231 (2020). [Google Scholar]
  • L. Zhou, Y. Liu. Wnt/β-catenin signaling and podocyte dysfunction in proteinuric kidney disease. Nat. Rev. Nephrol. 11, 535–545 (2015). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.